[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU1748001A - Pharmaceutical composition for treatment of diarrhea - Google Patents

Pharmaceutical composition for treatment of diarrhea

Info

Publication number
AU1748001A
AU1748001A AU17480/01A AU1748001A AU1748001A AU 1748001 A AU1748001 A AU 1748001A AU 17480/01 A AU17480/01 A AU 17480/01A AU 1748001 A AU1748001 A AU 1748001A AU 1748001 A AU1748001 A AU 1748001A
Authority
AU
Australia
Prior art keywords
diarrhea
treatment
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17480/01A
Inventor
Thomas Akerlund
Lars G. Burman
Sture Karlsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Karolinska Innovations AB
Original Assignee
Karolinska Innovations AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karolinska Innovations AB filed Critical Karolinska Innovations AB
Publication of AU1748001A publication Critical patent/AU1748001A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU17480/01A 1999-11-16 2000-11-15 Pharmaceutical composition for treatment of diarrhea Abandoned AU1748001A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9904132A SE9904132D0 (en) 1999-11-16 1999-11-16 Pharmaceutical composition for treatment of diarrhea
SE9904132 1999-11-16
PCT/SE2000/002241 WO2001035983A1 (en) 1999-11-16 2000-11-15 Pharmaceutical composition for treatment of diarrhea

Publications (1)

Publication Number Publication Date
AU1748001A true AU1748001A (en) 2001-05-30

Family

ID=20417728

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17480/01A Abandoned AU1748001A (en) 1999-11-16 2000-11-15 Pharmaceutical composition for treatment of diarrhea

Country Status (5)

Country Link
EP (1) EP1229926A1 (en)
AU (1) AU1748001A (en)
CA (1) CA2402811A1 (en)
SE (1) SE9904132D0 (en)
WO (1) WO2001035983A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2156846B1 (en) * 2007-05-08 2014-08-13 Ajinomoto Co., Inc. Prophylactic or therapeutic agent for diarrhea
GB2527802B (en) * 2014-07-02 2019-10-16 Olimed Ltd An orally disintegrating tablet with differentiated absorption
WO2020035720A1 (en) 2018-08-17 2020-02-20 Universidad Andrés Bello Method and pharmacological composition for the prevention of recurrent infections caused by clostridium difficile.
WO2023079335A1 (en) 2021-11-03 2023-05-11 Universidad Andrés Bello Composition based on nystatin and vancomycin nanoparticles for the treatment of clostridioides difficile infection and prevention of recurrence

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4587265A (en) * 1983-02-07 1986-05-06 St. Louis University Inhibition of diarrhea induced by Escherichia coli heat-stable enterotoxin
WO1995003063A1 (en) * 1993-07-22 1995-02-02 Esseti S.A.S. Laboratorio Chimico Farmaco Biologico Di A. Ievoli & C. Oral pharmaceutical compositions comprising reduced glutathion
DE59712694D1 (en) * 1997-04-18 2006-08-24 Fritz Stanislaus STABILIZED MEDICAMENT CONTAINING CYSTEINYL DERIVATIVES

Also Published As

Publication number Publication date
EP1229926A1 (en) 2002-08-14
WO2001035983A1 (en) 2001-05-25
SE9904132D0 (en) 1999-11-16
CA2402811A1 (en) 2001-05-25

Similar Documents

Publication Publication Date Title
AU7389300A (en) Methods of administration of glycopyrrolate compositions
AU3192700A (en) Medicinal compositions
AU2001233081A1 (en) Composition for treatment of stress
AU5326100A (en) Pharmaceutical compositions and methods for use
AU3556400A (en) Pharmaceutical compositions
AU1774097A (en) Pharmaceutical compositions for the treatment of rhinitis
AU2005300A (en) Medicinal compositions
AU1887401A (en) Medicinal composition
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU4392199A (en) Medicinal compositions for treating evacuatory insufficiency
AU2792700A (en) Pharmaceutical composition containing cyclosporin
AU6460400A (en) Pharmaceutical compositions
AU2670600A (en) Pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence
AU1878201A (en) Composition for the treatment of damaged tissue
AU2021601A (en) Composition for the treatment of dandruff
AU6460200A (en) Pharmaceutical compositions
AU4417000A (en) Novel pharmaceutical composition suitable for gene therapy
AU1748001A (en) Pharmaceutical composition for treatment of diarrhea
AU5704800A (en) Medicinal compositions for preventing or treating diarrhea
AU5494298A (en) Pharmaceutical compositions for the treatment of the eye
AU6460100A (en) Pharmaceutical compositions
AU6460300A (en) Pharmaceutical compositions
AU5245600A (en) Medicinal compositions for treating lower uropathy
HUP0002508A3 (en) Pharmaceutical compositions for treatment of migraine
AU4914400A (en) Novel pharmaceutical composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase